Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-005781

EVP, GM Cell Therapy acquired 53,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Groot Eleanor EVP, GM Cell Therapy 2020-01-29 Grant or award +53,700 228,033 D
Derivatives
De Groot Eleanor EVP, GM Cell Therapy 2020-01-29 Grant or award · Employee Stock Option (right to buy) +82,600 82,600 D
Loading xslF345X03/doc4.xml…